信达生物与礼来达成重磅合作，港股通创新药ETF易方达涨1.77%

财闻02-09

截止2月9日10点23分，上证指数涨1.26%，深证成指涨1.69%，创业板指涨2.08%。光伏设备、影视院线、HJT电池等板块涨幅居前。　　ETF方面，港股通创新药ETF易方达（159316）涨1.77%，成分股康诺亚-B、信达生物涨超5%，四环医药、再鼎医药、石药集团、百济神州、中国生物制药、映恩生物-B、复星医药（600196）、华润医药等上涨。　　消息面上，信达生物于2月8日宣布与礼来制药...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2610558688?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-02-09 10:44","share_image_url":"https://static.laohu8.com/f0343184bd9b9c963ed02b302442e2b8","id":"2610558688","market":"sh","top_or_hot":-1,"title":"信达生物与礼来达成重磅合作，港股通创新药ETF易方达涨1.77%","media":"财闻","content":"<div>\n<p>截止2月9日10点23分，上证指数涨1.26%，深证成指涨1.69%，创业板指涨2.08%。光伏设备、影视院线、HJT电池等板块涨幅居前。　　ETF方面，港股通创新药ETF易方达（159316）涨1.77%，成分股康诺亚-B、信达生物涨超5%，四环医药、再鼎医药、石药集团、百济神州、中国生物制药、映恩生物-B、复星医药（600196）、华润医药等上涨。　　消息面上，信达生物于2月8日宣布与礼来制药...</p>\n\n<a href=\"http://fund.10jqka.com.cn/20260209/c674649029.shtml\">网页链接</a>\n\n</div>\n","source":"tonghuashun","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>信达生物与礼来达成重磅合作，港股通创新药ETF易方达涨1.77%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n信达生物与礼来达成重磅合作，港股通创新药ETF易方达涨1.77%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-09 10:44 北京时间&nbsp;&nbsp;&nbsp;<a href=http://fund.10jqka.com.cn/20260209/c674649029.shtml><strong>财闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>截止2月9日10点23分，上证指数涨1.26%，深证成指涨1.69%，创业板指涨2.08%。光伏设备、影视院线、HJT电池等板块涨幅居前。　　ETF方面，港股通创新药ETF易方达（159316）涨1.77%，成分股康诺亚-B、信达生物涨超5%，四环医药、再鼎医药、石药集团、百济神州、中国生物制药、映恩生物-B、复星医药（600196）、华润医药等上涨。　　消息面上，信达生物于2月8日宣布与礼来制药...</p>\n\n<a href=\"http://fund.10jqka.com.cn/20260209/c674649029.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"520880","symbol_name":"港股通创新药ETF","start_time":0,"source_url":"http://fund.10jqka.com.cn/20260209/c674649029.shtml","article_id":"2610558688","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2610558688","pubTimestamp":1770605040,"columns":[],"sourceInfo":{"source_id":"tonghuashun","name":"同花顺"},"weMediaInfo":null,"summary":"截止2月9日10点23分，上证指数涨1.26%，深证成指涨1.69%，创业板指涨2.08%。光伏设备、影视院线、HJT电池等板块涨幅居前。ETF方面，港股通创新药ETF易方达（159316）涨1.77%，成分股康诺亚- ...","collect":0,"end_time":0,"defaultTopTitle":"10jqka.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"520880":"港股通创新药ETF"},"translate_title":"Innovent Biologics and Eli Lilly reached a blockbuster cooperation, and the Hong Kong Stock Connect innovative drug ETF E Fund rose 1.77%","themeId":"34f23f16691bc3dd0945b028f8bb922f","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"520880":1.5},"content_text":"截止2月9日10点23分，上证指数涨1.26%，深证成指涨1.69%，创业板指涨2.08%。光伏设备、影视院线、HJT电池等板块涨幅居前。　　ETF方面，港股通创新药ETF易方达（159316）涨1.77%，成分股康诺亚-B、信达生物涨超5%，四环医药、再鼎医药、石药集团、百济神州、中国生物制药、映恩生物-B、复星医药（600196）、华润医药等上涨。　　消息面上，信达生物于2月8日宣布与礼来制药达成战略合作，共同推进肿瘤及免疫领域创新药物的全球研发。根据协议，信达生物将获得3.5亿美元首付款，并有资格获得总额最高约85亿美元的里程碑付款及销售分成。这一高额交易进一步验证了中国创新药企的研发实力与国际竞争力，是近期创新药板块出海逻辑的重要催化事件。　　湘财证券表示，近期在国家鼓励创新大背景下创新药产业链表现活跃，虽然医药工业复苏仍有待验证，行业受医保控费压力仍在，但多层次的支付体系正在建立，医疗需求的刚性将共同推动行业企稳回升，综上我们维持医疗服务行业“买入”评级。　　光大证券表示，随着国内外宏观和政策形势的变化，我们认为未来医药板块的投资应当越来越着重于医药的临床价值本质逻辑，即解决医患的临床需求。无论是国内的医保政策，还是出海的全球布局，均对于临床价值赋予越来越高的溢价。从临床价值三段论出发，我们看好创新药产业链、创新医疗（002173）器械。　　港股通创新药ETF易方达（159316）紧密跟踪恒生创新药指数，恒生创新药指数反映业务与创新药研究、开发及生产相关的香港上市公司之表现。 \n关注同花顺财经（ths518），获取更多机会","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2610558688","isCrawlerRequest":true}